2012-2013 Officers

• Robert M. Wachter, MD, Chair
• David H. Johnson, MD, Chair-Elect
• Patricia M. Conolly, MD, Secretary
• Stuart L. Linas, MD, Treasurer
• Richard J. Baron, MD, President

2012 - 2013 Directors

• Charles S. Abrams, MD
• Lee R. Berkowitz, MD
• Shalendar Bhasin, MD
• Clarence H. Braddock III, MD
• William J. Bremner, MD
• Marie T. Brown, MD
• David L. Coleman, MD
• David H. Ellison, MD
• Christopher E. Forsmark, MD
• David P. Huston, MD
• George H. Karam, MD
• Harlan M. Krumholz, MD
• Sharon A. Levine, MD
• William C. Little, MD
• Naomi P. O'Grady, MD
• Olufunmilayo Olopade, MD
• Neil R. Powe, MD
• Richard P. Shannon, MD
• Christine A. Sinsky, MD
• Richard M. Stone, MD
• Joan M. Von Feldt, MD
• Keith R. Young MD

Robert M. Wachter, MD

Dr. Wachter, a board certified internist, is Professor of Medicine at the University of California, San Francisco (UCSF), Associate Chairman of UCSF’s Department of Medicine, Chief of the Medical Service at UCSF Medical Center, and Chief of UCSF’s 50-faculty Division of Hospital Medicine.

Dr. Wachter, who has published 250 articles and six books, is an expert in patient safety, quality and the organization of hospital care. He coined the term “hospitalist” in a 1996 New England Journal of Medicine article, and is generally considered the academic leader of the field, the fastest growing specialty in modern medical history. He is a past president of the Society of Hospital Medicine.

He is also a national leader in the fields of patient safety and health care quality. He is editor of AHRQ WebM&M, an online case-based patient safety journal, and AHRQ Patient Safety Network, the leading federal patient safety portal. Together, these websites receive three million visits each year. He is a past recipient of the John M. Eisenberg award, the nation’s top honor in patient safety, and was a 2011 US-UK Fulbright scholar, studying safety at Imperial College London. He has written two books on patient safety, including Understanding Patient Safety, whose second edition was published in 2012. His blog, Wachter's World (www.wachtersworld.org) is one of the nation's most popular health care blogs. Modern Physician magazine has ranked him as one of the 50 most influential physicians in the U.S. for each of the last five years, the only academic physician to achieve this recognition

David H. Johnson, MD

Dr. Johnson, who is board certified in internal medicine and medical oncology, is the Donald W. Seldin Distinguished Chair in Internal Medicine and Chairman of the Department of Internal Medicine at UT Southwestern Medical Center in Dallas, Texas. He is Chair-elect of the American Board of Internal Medicine Board of Directors. Previously he served on the ABIM Subspecialty Board on Medical Oncology (2001-2011) and chaired the Board from 2007 until 2011.

From 1983 to 2010, he was a member of the faculty at the Vanderbilt University Medical School where he held the Cornelius A. Craig Chair of Medical and Surgical Oncology and served as the Director of the Division of Hematology and Medical Oncology and Deputy Director of the Vanderbilt-Ingram Cancer Center, of which he was a founding member.

In 2004-2005, Dr. Johnson served as President of the American Society of Clinical Oncology (ASCO) during which time he helped advance ASCO’s quality of care activity known as the Quality Oncology Practice Initiative (or QOPI®). QOPI serves as a Practice Improvement Module for ABIM. He also led an effort to establish ASCO’s Cancer Survivorship Program. Dr. Johnson has served on the Food and Drug Administration’s Oncology Drug Advisory Committee, as Chairman of the Thoracic Committee of the Eastern Cooperative Oncology Group and on the Board of Directors of the National Comprehensive Cancer Network, the International Association for the Study of Lung Cancer and the LiveSTRONG Foundation. He has authored more than 350 peer reviewed articles and 40 book chapters and edited four oncology textbooks.

Dr. Johnson earned his medical degree from the Medical College of Georgia and obtained his medical oncology training at Vanderbilt University.

Patricia M. Conolly, MD

Dr. Conolly, a board certified internist, is Associate Executive Director of The Permanente Medical Group where she has oversight of multiple services that impact greater than three million members of Kaiser Permanente in Northern California. Her current work includes the development and use of technology in health care delivery with three key areas of emphasis: leveraging the electronic medical record to improve quality, developing applications to engage patients in understanding and managing their health, and extending the reach of the delivery system to patients where and when they need care. Of particular interest is the development of Web-based applications to support informed decision-making.

Dr. Conolly currently practices at Kaiser Permanente’s Oakland Medical Center where she was Chief of Medicine and Director of their Internal Medicine Residency Program as well as Director of Medical Education. She chaired Kaiser Permanente's Northern California Pharmacy and Therapeutics Committee, overseeing evidence-based clinical guidelines for medication use as well as the formulary process. Dr. Connolly, a member of the American Board of Internal Medicine's Board of Directors, serves as its secretary.

Dr. Conolly earned her medical degree from the University of California, Los Angeles, and served on the clinical faculty at the University of California, San Francisco School of Medicine. She continues as a clinical preceptor in the UC Berkeley/UC San Francisco Joint Medical Program. She is a Fellow of the American College of Physicians.

Stuart L. Linas, MD

Dr. Linas, a board certified internist and nephrologist, is the Rocky Mountain Professor of Renal Research at the University of Colorado Denver School of Medicine (UCDSOM). He has served on the faculty at the University of Colorado throughout his academic career and has been the Renal Fellowship Director since 1984 and the Head of the Section of Hypertension within the Division of Renal Diseases since 1994. Dr. Linas is the Chief of Nephrology at Denver Health Medical Center.

He has won numerous teaching awards from medical students and house staff at the University of Colorado. He currently chairs the Curriculum Steering Committee at the UCDSOM. Dr. Linas is the treasurer of the American Board of Internal Medicine Board of Directors as well as its former secretary. He is also a past Chair of the ABIM Subspecialty Board on Nephrology. He is on the Board of Advisors and has served as the Chair of the Renal Fellowship Program Directors for the American Society of Nephrology. He has served as the President of the Association of Specialty Professors and on the board of directors of the Alliance of Academic Internal Medicine.

After earning a medical degree from Tufts University School of Medicine, he completed internal medicine residency at the University of Rochester School of Medicine and nephrology training at the University of Colorado.

Richard J. Baron, MD, President

Dr. Baron, board certified in internal medicine and geriatrics, is President and CEO of the American Board of Internal Medicine and the ABIM Foundation. Dr. Baron was a former Chair of the American Board of Internal Medicine’s Board of Directors.

Previously, Dr. Baron served as Group Director of Seamless Care Models at the Centers for Medicare & Medicaid Services (CMS) Innovation Center, where he led efforts related to Accountable Care Organizations and primary care. Prior to his CMS appointment, Dr. Baron practiced general internal medicine and geriatrics at Greenhouse Internists, P.C., located in Philadelphia. Greenhouse has been a pioneer in the comprehensive adoption of electronic health records in the small-practice environment. Until joining the federal government, Dr. Baron also served on the Board of the National Quality Forum and their Health Information Technology Advisory Committee, as well as the Standards Committee of the National Committee for Quality Assurance.

Dr. Baron served as Chief Medical Officer of Health Partners, a not-for-profit Medicaid HMO set up by four teaching hospitals in Philadelphia, from 1988 to 1996. He was the architect of the Best Clinical and Administrative Practices program, funded by the Robert Wood Johnson Foundation and the Center for Health Care Strategies, working with medical leadership of Medicaid health plans around the country in learning collaboratives to improve the quality of care for their members. This program reached plans serving more than half of the Medicaid managed care population in the United States.

Dr. Baron received an English degree from Harvard College and his medical degree from Yale University. He completed house staff training at New York University-Bellevue Medical Center and served a three-year obligation in the National Health Service Corps in rural Tennessee.

Charles S. Abrams, MD

Dr. Abrams, who is board certified in internal medicine, hematology and medical oncology, is Associate Chief of Hematology-Oncology at the University of Pennsylvania School of Medicine.

Dr. Abrams is a sought-after lecturer on topics related to hematology/oncology. His recent publications have appeared in Blood, the Proceedings of the National Academy of Science and Science.

Dr. Abrams serves as Chair of ABIM’s Subspecialty Board on Hematology. He is the Secretary of American Society of Hematology, and serves on their Executive Committee. Dr. Abrams has been elected to the American Society for Clinical Investigation and the Association of American Physicians. He was recently the Chair of the Hemostasis-Thrombosis Study Section of the National Institutes of Health Center for Scientific Review, and has formerly chaired the Thrombosis Study Section of the National American Heart Association.

Lee R. Berkowitz, MD

Dr. Berkowitz, a board certified internist and hematologist, is the Eunice Bernhard Distinguished Professor and Associate Chair of Education in the Division of General Internal Medicine at the University of North Carolina (UNC) at Chapel Hill. His academic career has centered on his role as Residency Program Director at UNC.

Currently, Dr. Berkowitz serves as a member of the ABIM Internal Medicine Exam Writing Committee and as Chair of the Alliance for Academic Medicine’s Task Force on Education Redesign of Graduate Medical Education. He has served as President of the Association of Program Directors in Internal Medicine and as Chair of the In-training Examination Test Writing Committee of the American College of Physicians.

Dr. Berkowitz earned his medical degree at the Ohio State University College of Medicine. He did his residency and chief residency in the Department of Medicine at the University of North Carolina at Chapel Hill and later completed fellowship training in hematology at Washington University and UNC.

Shalendar Bhasin, MD

Dr. Bhasin, a board certified internist and endocrinologist, is Professor of Medicine at Boston University School of Medicine, and Chief of the Section of Endocrinology, Diabetes, and Nutrition at Boston Medical Center in Boston, Massachusetts. He serves as Chair of the ABIM Subspecialty Board on Endocrinology, Diabetes, and Metabolism.

Dr. Bhasin is an internationally recognized endocrinologist and serves as Chair of the Endocrine Society’s Clinical Guidelines Subcommittee. He is an Associate Editor for the Journal of Clinical Endocrinology and Metabolism, and is director of The Boston Claude D. Pepper Older Americans Independence Center for Function Promoting Therapies. He is a former Chair of Endocrine Society’s Expert Panel for the development of Guidelines for Testosterone Therapy. His laboratory provided the first unequivocal evidence of the anabolic effects of androgens in humans, demonstrated that androgens regulate differentiation of mesenchymal stem cells, and invoked the activation of Wnt target genes through beta-catenin-TCF-4 pathway. He is a translational researcher, supported by several National Institutes of Health-funded grants for more than 20 years, and has been the recipient of numerous teaching and research awards.

Dr. Bhasin obtained his medical education at the All India Institute of Medical Sciences in New Delhi, India. He received his residency training at Northwestern University Medical School and fellowship training in Endocrinology and Nutrition at Harbor-UCLA Medical Center in Los Angeles, California.

Clarence H. Braddock, III, MD

Dr. Braddock, a board certified internist, is Professor of Medicine at Stanford University School of Medicine. There he holds several positions, including Associate Dean for Medical Education, Associate Chief in General Internal Medicine, Associate Chair for Organizational Improvement in Medicine and Director of Clinical Ethics at the Stanford Center for Biomedical Ethics. He is also a member of the American Board of Internal Medicine (ABIM)’s Board of Directors and is Chair of ABIM’s PIM Oversight Committee.

Dr. Braddock has been a national leader in medical education, particularly in bioethics. He launched the Bioethics Education Project at University of Washington, an initiative to expand ethics and professionalism education, and the Practice of Medicine program at Stanford, a new initiative to integrate ethics, professionalism, doctor-patient communication and population health into the pre-clerkship medical school curriculum. His research has focused on shared decision-making and patient-physician communication, having developed a framework for teaching and for evaluation of practice.

Dr. Braddock is currently Chair of the Ethics Committee for the Society of General Internal Medicine and serves on the Ethics, Professionalism and Human Rights Committee for the American College of Physicians. He is Director of the National Consortium for Multicultural Education for Health Professionals, a group of 18 medical schools funded by the National Heart, Lung and Blood Institute to develop curriculum in cultural competence and health care disparities.

Dr. Braddock earned his undergraduate degree at Stanford University and medical degree at the University of Chicago. He completed residency training in the U.S. Navy and received his master’s in public health degree in health care ethics from the University of Washington.

William J. Bremner, MD

Dr. Bremner, a board certified internist, is the Robert G. Petersdorf Endowed Chair in Medicine and Professor and Chair of the Department of Medicine at the University of Washington School of Medicine. He is Co-Founder and Director of the Center for Research in Reproduction and Contraception at the University of Washington. Funded continuously by the NIH since 1979, the Center investigates the basic biology of male reproduction, infertility and contraception. Dr. Bremner is also an active physician and teacher at University of Washington Medical Center in Seattle.

He is the author or co-author of over 200 scientific publications and over 50 book chapters and has held more than 100 invited lectureships and visiting professorships around the world over the past 25 years. He is a member of Alpha Omega Alpha Medical Honorary and a recipient of the Henry Christian Award for Excellence in Research from the American Federation for Clinical Research. In 2003, he received the University of Washington School of Medicine Distinguished Alumni Award; and in 2005, he was given the Mayo Soley Award by the Western Society for Clinical Investigation in recognition of lifetime achievement in scientific endeavors and for his concern for junior faculty. He has been elected to the scientific and honorary societies: American Society for Clinical Investigation and the Associations of American Physicians.

He is the past President of the Association of Professors of Medicine (APM) and the American Society of Andrology. He has served on numerous national and international bodies, including NIH review groups, the Steering Committee for the World Health Organization Special Program on Research in Human Reproduction and the Expert Advisory Committee, Agency for International Development/CONRAD Program and the U.S. Department of Veterans Affairs Blue Ribbon Panel on Academic Affiliations.

Marie T. Brown, MD

Dr. Brown, a practicing, board certified internist and geriatrician, is an Assistant Professor of Medicine, Department of Internal Medicine, Rush University Medical Center Chicago, Illinois.

Dr. Brown serves as a Director for the American Board of Internal Medicine and is Chair of the ABIM Internal Medicine Exam Writing Committee. She is Governor of the Illinois Chapter-Northern region of the American College of Physicians. She currently serves on the Board of Directors of the Council of Medical Specialty Societies as Treasurer.

Her publications include reviews in the Mayo Clinic Proceedings and the American Journal of Medicine. She served on the Board of Directors for the Iowa Foundation for Medical Care and on the Board of Managers for the Illinois Foundation for Quality Health Care, the statewide quality improvement organizations for Illinois and Iowa. Dr. Brown was a member of the American College of Physicians Scientific Program Committee for 2005 and Chair of the Scientific Program Subcommittee for the American College of Physicians Annual Session 2007, and currently serves on the national ACP Medical Education Committee.

After earning her medical degree from Rush Medical College in Chicago, she completed an internship and residency in internal medicine at Rush-Presbyterian-St. Luke’s Hospital. She became a Fellow of the American College of Physicians in 1993.

David L. Coleman, MD

Dr. Coleman, a board certified internist and infectious disease specialist, is the John Wade Professor and Chair of the Department of Medicine at the Boston University School of Medicine. He has had a long-standing interest in basic mechanisms of macrophage function and the role of cytokines in regulating host defenses. His recent work has focused on medical and civic professionalism in medical education and clinical practice.

Prior to assuming his current position, Dr. Coleman was Chief of Medical Service at the VA Connecticut Healthcare System and Interim Chair of the Department of Medicine at Yale University School of Medicine.

He serves on the Board of Trustees of the Boston Medical Center, on the Board of Directors of the Faculty Practice Plan of Boston Medical Center and Boston University School of Medicine, and is a member of the Executive Committee at Boston University School of Medicine. Dr. Coleman is a Fellow of the American College of Physicians. He is also a member of the Association of Professors of Medicine (APM) and serves on the Editorial Board of Infection.

A graduate of Stanford University, Dr. Coleman completed his medical degree at the University of California, San Francisco. He did his residency and fellowship in the Department of Internal Medicine at Yale University, where he also served as Chief Resident.

David H. Ellison, MD

Dr. Ellison, a board certified internist and nephrologist, is Professor of Medicine and Physiology and Pharmacology and Head of the Division of Nephrology and Hypertension at Oregon Health & Science University. He is also a staff physician at the Portland VA Medical Center, a practicing nephrologist with an active clinical practice and a dedicated teacher and mentor to medical students, residents, nephrology fellows and post-doctoral scientists. He has won numerous awards for his teaching activities.

Dr. Ellison serves as Chair of the ABIM Subspecialty Board on Nephrology. He is a member of Alpha Omega Alpha and the Association of American Physicians. He was Chair of the Council on the Kidney in Cardiovascular Disease of the American Heart Association from 2010-2012 and was Program Chair for the Annual Meeting of the American Society of Nephrology in 2010.

Dr. Ellison has published widely in the area of human blood pressure variation, treatment of heart failure, diuretic resistance and hypertension pathogenesis. He research has focused on how thiazide diuretics, drugs recommended as first line antihypertensive agents, inhibit salt transport and reduce blood pressure. His laboratory has investigated how mutations in protein kinases cause human hypertension and how drugs, such as calcineurin inhibitors, raise the blood pressure. This work is expected to lead to the development of new types of drugs to treat hypertension, the most common disease in the United States and in Western countries. He is a member of study sections at both NIH and the Department of Veterans Affairs, and was the recipient of the OHSU Faculty Senate Award for Outstanding Research in 2011.

A graduate of Stanford University, Dr. Ellison completed his medical degree at Rush University. He completed residency in internal medicine at Oregon Health & Science University, followed by fellowship in nephrology at Yale University.

Christopher E. Forsmark, MD

Dr. Forsmark, who is board certified in internal medicine and gastroenterology, is Professor of Medicine and the Chief of the Division of Gastroenterology, Hepatology and Nutrition at the University of Florida (UF). He also serves as the Training Program Director for the UF Gastroenterology Fellowship program. Dr. Forsmark is Chair of the ABIM Subspecialty Board on Gastroenterology.

His clinical and research interests are in the areas of acute and chronic pancreatitis, pancreatic function and function testing, biliary and pancreatic malignancy, and advanced therapeutic endoscopy. He is the former president of the American Pancreatic Association and the current Chair of the Pancreatic Section of the American Gastroenterologic Association. He is the author of many book chapters, reviews and editorials, and original research in these areas of focus.

David P. Huston, MD

Dr. Huston is Vice Dean for Texas A&M University Health Science Center College of Medicine, Professor of Medicine and of Microbial and Molecular Pathogenesis, and Director for the Texas A&M Clinical and Translational Research Institute. He is board certified in allergy and immunology, diagnostic and laboratory immunology, rheumatology and internal medicine.

Previously, he served for 28 years on the faculty at Baylor College of Medicine, where he was Professor of Medicine and Immunology, Cullen Chair in Immunology, Director of the Biology of Inflammation Center, and Co-Director of the HHMI Translational Biology and Molecular Medicine program in the Graduate School of Biomedical Sciences.

Dr. Huston’s research is focused on mechanisms of allergic inflammation. He is a NIH-funded investigator with more than 100 publications and several patents, and has served on NIH study sections for more than 20 years. Consistently listed among the Best Doctors in America, Dr. Huston has held a number of national leadership positions in the American Academy of Allergy Asthma and Immunology and the Clinical Immunology Society, and has served on several editorial boards and as a consultant with NASA for human research on the international space station. Dr. Huston currently serves on the Board of Directors for the American Board of Allergy and Immunology, the American Board of Internal Medicine and the American Academy of Allergy Asthma and Immunology and is a member of the ACGME Residency Review Committee for Allergy and Immunology and of the American Board of Medical Specialties Health and Public Policy Committee. In addition, he has been elected to the American Clinical and Climatological Association and to the Association of American Physicians.

Dr. Huston received his bachelor’s degree in biology from Wofford College and his medical degree from Wake Forest University. He trained in internal medicine at Baylor College of Medicine and completed fellowship training in rheumatology and in allergy and immunology at the National Institutes of Health.

George H. Karam, MD

Dr. Karam, a board certified internist and infectious disease specialist, is the Paula Garvey Manship Professor of Medicine at the Louisiana State University School of Medicine. He serves as Chair of the ABIM Subspecialty Board on Infectious Disease.

He is a member of many professional associations including the Association of Professors of Medicine, Association of Program Directors in Internal Medicine and Infectious Disease Society of America. His work has been published extensively in leading professional journals, including Journal of Infectious Diseases, New England Journal of Medicine and Annals of Internal Medicine.

Dr. Karam received his medical degree from the Louisiana State University School of Medicine.

Harlan M. Krumholz, MD

Dr. Krumholz, a board certified internist and cardiovascular disease specialist, is the Harold H. Hines Jr. Professor of Medicine and Epidemiology and Public Health at Yale University School of Medicine, where he is Director of the Robert Wood Johnson Clinical Scholars Program. He is also the Director of the Yale-New Haven Hospital Center for Outcomes Research and Evaluation.

His research is focused on determining optimal clinical and population-based strategies for improving the prevention, treatment and outcome of cardiovascular disease. The research and its application has contributed to elevating the quality of practice, eliminating disparities, defining new treatment standards, improving professional standards and guiding health care policy.

Dr. Krumholz is an elected member of the Association of American Physicians, the American Society for Clinical Investigation and the Institute of Medicine. He was named an American Heart Association Distinguished Scientist.

Dr. Krumholz earned his medical degree from Harvard Medical School and a Master’s degree in health policy and management at the Harvard School of Public Health. He trained in internal medicine at the University of California, San Francisco and in cardiology at Beth Israel in Boston.

Sharon A. Levine, MD

Dr. Levine is a board certified internist and geriatrician and Professor of Medicine at Boston University School of Medicine, where she served as the Associate Dean for Academic Affairs. She is currently the Director of Geriatric Educational Innovations in the Geriatrics Section. Among her many significant contributions to geriatrics education, Dr. Levine created Boston University’s Chief Resident Immersion Training (CRIT) in the Care of Older Adults. The program focuses on providing chief residents with knowledge and confidence to practice and teach geriatrics and to develop leadership and teaching skills needed in their chief resident roles. The program has been offered at 19 other institutions nationwide, through national dissemination projects supported by the John A. Hartford Foundation, the Hearst Foundations and the Donald W. Reynolds Foundation, which will bring the model to 40 institutions by 2015.

A member of the American Board of Internal Medicine’s Board of Directors, Dr. Levine is Chair of the ABIM Subspecialty Board on Geriatric Medicine. She is also a fellow of the American Geriatrics Society (AGS). She was awarded the AGS’s Dennis W. Jahnigen Memorial Award in 2011 for her outstanding leadership in advancing geriatrics education in health professions schools. She is also the winner of Boston University’s prestigious Metcalf Cup and Prize, the Society of General Internal Medicine’s New England Educator of the Year award, and the Boston University Department of Medicine’s Robert Dawson Evans Special Recognition Teaching Award. Dr. Levine has served on numerous national education committees and has supported and inspired trainees at all levels. She has authored peer-reviewed publications that focus on the dissemination of innovative teaching models and faculty development programs in geriatrics.

She received her medical degree from Albert Einstein College of Medicine and completed her residency in Internal Medicine at Yale-New Haven Hospital, where she taught before coming to Boston.

William C. Little, MD

Dr. Little, who is board certified in internal medicine, cardiovascular disease and interventional cardiology, is McMichael Professor of Cardiology and Vice-Chair of the Department of Internal Medicine at the Wake Forest University School of Medicine in Winston-Salem, North Carolina.

Dr. Little is Chair of the ABIM Subspecialty Board on Cardiovascular Disease. He is a Fellow of the American Heart Association (Council on Clinical Cardiology) and the American College of Cardiology; a member of the American Society of Clinical Investigation, American Association of Physicians, Association of University Cardiologists, and the Association of Professors of Cardiology (President in 2005). He is also the 2010 recipient of the American Heart Association’s Laennec Master Clinician Award, and the American Physiological Society’s Lamport Award for Cardiac Research; and has served as the Chair of the NIH Cardiovascular Study Section and VA Cardiovascular Merit Review Board. Dr. Little is a respected and frequently-cited author, having published more than 240 peer-reviewed articles.

His key research accomplishments include: finding that myocardial infarction most common results from the sudden occlusion of a coronary artery that did not previously contain an obstructive stenosis; demonstrating the role of left ventricular (LV) diastolic dysfunction in the pathogenesis of acute pulmonary edema; the pathophysiologic characterization of heart failure with a preserved ejection fraction; the physiologic mechanisms of normal and abnormal LV filling at rest and during exercise; the importance of angiotensin II and endothelin in diastolic dysfunction; and the first detailed evaluation of the effect of dyssynchronous electrical activation on LV performance. Other contributions include methods of assessing LV systolic and diastolic performance and LV arterial coupling and the clinical characterization of Chagas’ disease. His current research activities include the evaluation of LV diastolic function using advanced imaging techniques and therapy for patients with heart failure and a preserved ejection fraction.

Naomi P. O'Grady, MD

Dr. O’Grady, who is board certified in Infectious Disease and Critical Care Medicine, is a senior staff physician in the National Institutes of Health (NIH) Clinical Center’s Critical Care Medicine Department and the Medical Director of the Clinical Center’s Vascular Access and Conscious Sedation Services. She also is an Attending Physician with the Pediatric Critical Care Medicine Department of the Children’s National Medical Center and an Assistant Professor in the Department of Internal Medicine’s Division of Infectious Diseases at Johns Hopkins University School of Medicine.

Dr. O’Grady’s research interests include strategies to reduce the incidence of antimicrobial resistant pathogens in the ICU and catheter-related blood stream infections. She is also actively involved in guideline development and implementation, having chaired the Infectious Diseases Society’s Guidelines Committee for three years. In addition, she has authored several guidelines related to fever in the ICU and catheter-related bloodstream infections.

Dr. O’Grady serves as Chair of the ABIM Subspecialty Board on Critical Care Medicine. She is a Fellow of the American College of Critical Care Medicine and of the Infectious Diseases Society of America.

A graduate of the University of Michigan, Dr. O’Grady earned her medical degree at Ohio State University and completed fellowships with NIH and Johns Hopkins University.

*Dr. O'Grady serves in a personal capacity and does not represent the National Institutes of Health or the Department of Health and Human Services.

Olufunmilayo I. Olopade, MD

Dr. Olopade, a board certified internist, medical oncologist and hematologist, is the Walter L. Palmer Distinguished Service Professor of Medicine and Associate Dean of Global Health at the University of Chicago. Her research on the genetic causes of breast cancer was instrumental in creating the Center for Clinical Cancer Genetics at the University of Chicago. She is the Program Director of Fellowship Training for the Section of Hematology/Oncology and a professor both in that department and the Department of Human Genetics at the University of Chicago’s Pritzker School of Medicine. She is also a practicing clinician and Director of the University’s Cancer Risk Clinic.

Dr. Olopade, an internationally recognized leader in human genetics and the causes of breast cancer, has served on numerous professional organizations including as Chair for the American Society of Clinical Oncology Cancer Genetics Education Task Force. She is a frequent lecturer in the U.S. and abroad and has been honored numerous times for her contributions to medicine, perhaps most notably with a MacArthur Fellowship Genius Award, an honorary degree from Princeton University, as Fellow in the American Academy of Arts and Sciences, as recipient of the AACR Distinguished Lecture on the Science of Cancer Health Disparities and with membership in the American Philosophical Society.

Dr. Olopade studied medicine in her native Nigeria, where she earned an MBBS (or Bachelor of Medicine and Surgery) with distinctions in Pathology and Pediatrics from the University of Ibadan, Nigeria. After completing an internship in medicine, surgery, pediatrics and OB/GYN at the University College Hospital in Ibadan, Nigeria and serving as a medical officer at the Nigerian Navy Hospital in Lagos, Nigeria, Dr. Olopade completed her residency and chief residency at Cook County Hospital in Chicago. Following, she completed a post-doctoral fellowship in both hematology and oncology at the University of Chicago.

Neil R. Powe, MD

Dr. Powe, who is board certified in internal medicine, is Chief of the Medicine Service at San Francisco General Hospital and Constance B. Wofsy Distinguished Professor and Vice-Chair of Medicine at the University of California San Francisco. He is a member of the American Board of Internal Medicine Board of Directors.

His major interests are in improving discovery, education and clinical practice in medicine, making academic organizations function better, enhancing scholarship and multidisciplinary collaboration, and developing future talent and leadership in the health professions. Uniting medicine and public health, he has extensive experience in patient-oriented research, clinical epidemiology and outcomes and effectiveness research in chronic kidney disease. He has studied early referral of chronic kidney disease patients, patient-physician contact in dialysis care, cost-effectiveness of screening for proteinuria, racial differences in cardiovascular procedure use among CKD patients, effect of treatment modalities on survival, outcomes of dialysis care by type of ownership, access to transplantation and organ donation.

Dr. Powe is a member of the Institute of Medicine, the American Society of Clinical Investigation, the Association of American Physicians, the American Society of Epidemiology and a Master of the American College of Physicians. He is past Chair of the National Advisory Committee for Healthcare Research and Quality.

Dr. Powe earned his medical degree at Harvard Medical School and his master’s in public health at Harvard School of Public Health. He completed residency, was a Robert Wood Johnson Clinical Scholar and completed his master’s in business administration at the University of Pennsylvania. Prior to his role at UCSF, Dr. Powe served as the James Fries University Distinguished Service Professor of Medicine and Director of the Welch Center at Johns Hopkins.

Richard P. Shannon, MD

Dr. Shannon, a board certified internist and cardiologist, is the Frank Wister Thomas Professor and Chair of the Department of Medicine at the University of Pennsylvania School of Medicine. In 2006, he served as Penn’s Vice Chair for Clinical Affairs and shortly thereafter as Senior Vice Chair, before being permanently appointed to the position of Chair of the Department of Medicine in August 2007. Prior to that, he was the Claude R. Joyner Professor of Medicine at Drexel University College of Medicine and the Chair of the Department of Medicine at Allegheny General Hospital.

Dr. Shannon’s investigative interests are in the area of myocardial metabolism and retroviral infection. Currently, his work focuses on incretin hormone biology in cardiovascular disease. His laboratory is one of only a few such laboratories conducting translational research in conscious, chronically instrumented primates, canines and swine. Dr. Shannon’s current work is funded through NIH grants and other sponsored program funding, and he holds a U.S. patent on the application of GLP-1 in LV Systolic Dysfunction.

Dr. Shannon’s pioneering work in patient safety is chronicled in the chapter – “First, Do No Harm” – in the book, The Best Practice - How the New Quality Movement is Transforming Medicine, by Charles Kenney. His innovative work also has been featured in The Wall Street Journal and The New York Times, on CNN and CNBC news segments and ABC’s 20/20, and was a centerpiece for the PBS report entitled, “Remaking American Medicine.” Dr. Shannon is a member of the Board of Directors of the American Board of Internal Medicine and is an elected member of numerous other organizations, including The American Society of Clinical Investigations. He also serves on several editorial boards, including Circulation.

Dr. Shannon received his bachelor’s degree from Princeton University and his medical degree from the University of Connecticut School of Medicine. He did his training in internal medicine at Beth Israel Hospital, his cardiovascular training at Massachusetts General Hospital, and was the Francis Weld Peabody Fellow and Associate Professor of Medicine at Harvard Medical School.

Christine A. Sinsky, MD

Dr. Sinsky, a board certified internist, is a general internist at Medical Associates Clinic and Health Plans, in Dubuque, IA.

Dr. Sinsky is a Director with the American Board of Internal Medicine (ABIM), serving on its executive committee. She is also a fellow of the American College of Physicians (ACP) and the recipient of the Iowa ACP 2013 Laureate Award. She serves on the National Advisory Council for Improving Primary Care through Industrial and Systems Engineering, is a prior member of the National Committee for Quality Assurance’s Committee on Physician Programs, with oversight of the Patient Centered Medical Home (PCMH), and has served on the national advisory councils for the CMS Innovation Center’s Comprehensive Primary Care Initiative and the Veteran’s Administration’s Patient Activated Care Team Initiative. In 2011-12, she led a primary care project for the ABIM Foundation, entitled “In Search of Joy in Practice.”

Dr. Sinsky is a co-author of the Institute of Medicine’s 2011 report, “Health IT and Patient Safety: Building Safer Systems for Better Care.” and has twice provided testimony to the Office of the National Coordinator for HIT regarding the role of EHRs in care coordination and usability.

A frequent invited lecturer on practice innovation, redesign and the PCMH, Dr. Sinsky has presented to groups including the American Medical Association, the American College of Physicians, the Institute for Healthcare Improvement and the Patient Centered Primary Care Collaborative, as well as to private and academic medical centers. She serves on the national advisory board for Primary Care Progress and the editorial board for Family Practice Management. Her practice has been a level 3 Patient Centered Medical Home since 2008.

Dr. Sinsky received her bachelors and medical degrees from the University of Wisconsin, and completed her postgraduate residency at Gundersen Medical Foundation/La Crosse Lutheran Hospital, in LaCrosse, Wisconsin, where she served as Chief Medical Resident.

Richard M. Stone, MD

Dr. Stone, who is board certified in internal medicine, medical oncology and hematology, is the Director of the Adult Acute Leukemia Program at Dana-Farber, and Professor of Medicine at Harvard Medical School.

He is nationally recognized for his translational and clinical research concerning blood and bone marrow malignancies including acute leukemia, myeloproliferative disorders and myelodysplastic syndrome [MDS] (a bone marrow failure state that may convert to leukemia).

In addition to his work at Dana-Farber, Dr. Stone serves as Chair of the Medical Oncology Board of the American Board of Internal Medicine, Chair of the Medical Advisory Board of the Aplastic Anemia & MDS International Foundation and Chairman of the Leukemia Core Committee for the national cooperative trials group the Alliance.

Stone earned his medical degree from Harvard Medical School in 1981. He completed his internal medicine residency training at Brigham and Women’s Hospital, and his hematology-oncology fellowship at Dana-Farber.

Joan Von Feldt, MD

Dr. Von Feldt, who is board certified in rheumatology and internal medicine, is Professor of Medicine in the Division of Rheumatology at the University of Pennsylvania School of Medicine and Associate Chief of Staff-Education at the Philadelphia VA Medical Center. She is a clinician with recognized regional and national expertise in Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis and has an active clinical research focus. Her current research is on premature atherosclerotic disease in SLE and Health Literacy in the Rheumatic Diseases.

Dr. Von Feldt serves as Chair of the ABIM Subspecialty Board on Rheumatology. Currently, she is on the Board of Directors of the American College of Rheumatology and is Treasurer of the Pan American League of Associations of Rheumatology.

She has devoted significant time to educational activities at the University of Pennsylvania as a member of the Curriculum Committee and has served as Course Director for multiple courses. She is currently course director of the Differential Diagnosis Course for pre-clerkship students. In addition, she has also served as the Rheumatology Specialty Liaison for the internal medicine residency program and Program Director for the rheumatology training program.

Dr. Von Feldt has published over 60 peer-reviewed articles, editorials and book chapters. She is Associate Editor of Journal of Clinical Rheumatology and serves as an ad hoc reviewer for numerous other publications.

She received her medical degree from the Medical College of Pennsylvania and completed her fellowship in rheumatology at the University of Pennsylvania. Additionally, she holds a master’s degree in education.

Keith Randall Young Jr., MD

Dr. Young, a board certified internist, pulmonologist and allergist/immunologist, is the Chairman of the Division of Pulmonary and Critical Care Medicine at the Albert Einstein Medical Center in Philadelphia, PA. Prior to assuming that position in the Summer of 2011, he was a faculty member at the University of Alabama at Birmingham, where he directed the Division of Pulmonary/Allergy/Critical Care Medicine for 15 years and also served as the Director of the Adult Cystic Fibrosis Program, the Co-Principal Investigator of UAB’s site in the Cystic Fibrosis Foundation’s Therapeutics Development Network, and the Medical Director of VIVA Health, a health insurance company that is part of the UAB Health System.

His national positions have included serving as President of the Association of Specialty Professors, President of the Association of Pulmonary and Critical Care Medicine Program Directors and a member of the Board of Regents of the American College of Chest Physicians.

Dr. Young is a graduate of the Massachusetts Institute of Technology and Jefferson Medical College. He completed an internship and residency in internal medicine at the Yale-New Haven Hospital, where he remained for a chief residency in internal medicine and a fellowship in pulmonary and critical care medicine. Prior to joining the UAB faculty, he served a medical staff fellowship in the Laboratory of Immunoregulation at the National Institute of Allergy and Infectious Diseases. He serves as Chair of the ABIM Subspecialty Board on Pulmonary Disease.